Cargando…
The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome
Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are diseases caused by the interaction of genetic and non-genetic factors. Therefore, the aim of our study was to investigate the association between six common genetic polymorphisms and T2DM and MetS in males. A total of 120 T2DM, 75 Met...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413885/ https://www.ncbi.nlm.nih.gov/pubmed/37576792 http://dx.doi.org/10.2478/bjmg-2023-0003 |
_version_ | 1785087227303297024 |
---|---|
author | Zenoaga-Barbăroșie, C Berca, L Vassu-Dimov, T Toma, M Nica, MI Alexiu-Toma, OA Ciornei, C Albu, A Nica, S Nistor, C Nica, R |
author_facet | Zenoaga-Barbăroșie, C Berca, L Vassu-Dimov, T Toma, M Nica, MI Alexiu-Toma, OA Ciornei, C Albu, A Nica, S Nistor, C Nica, R |
author_sort | Zenoaga-Barbăroșie, C |
collection | PubMed |
description | Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are diseases caused by the interaction of genetic and non-genetic factors. Therefore, the aim of our study was to investigate the association between six common genetic polymorphisms and T2DM and MetS in males. A total of 120 T2DM, 75 MetS, and 120 healthy controls (HC) were included in the study. ACE ID, eNOS 4a/b, ATR1 A1166C, OXTR (A>G), SOD1 +35A/C, CAT-21A/T gene polymorphisms were genotyped by PCR or PCR-RFLP techniques. T2DM was diagnosed at an earlier age compared to MetS (54 vs 55 years old, p=0.0003) and the difference was greater in carriers of the OXTR G allele (54 vs 56 years old, p=0.0002) or both OXTR G and eNOS b alleles (54 vs 56, p=0.00016). The SOD1 AA genotype (O.R.=0.11, p=0.0006) and the presence of both ACE I and OXTR1 A (O.R.=0.39, p=0.0005) alleles revealed to be protective for T2DM. SOD1 AA and AC genotypes were protective factors for triglyceride (p=0.0002 and p=0.0005, respectively) and HDL cholesterol (p=0.0002 and p=0.0004, respectively) levels in T2DM patients. ACE DD was identified more frequently in hypertensive T2DM patients (O.R.=3.77, p=0.0005) and in those who reported drinking alcohol (p=0.0001) comparing to HC and T2DM patients who did not drink alcohol, respectively. We observed that T2DM patients who reported drinking alcohol had an increased frequency of ACE DD and eNOS bb (p<0.0001), or ACE DD and OXTR G (p<0.0001) compared to non-drinkers. No gene polymorphisms were associated with MetS. |
format | Online Article Text |
id | pubmed-10413885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Sciendo |
record_format | MEDLINE/PubMed |
spelling | pubmed-104138852023-08-11 The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome Zenoaga-Barbăroșie, C Berca, L Vassu-Dimov, T Toma, M Nica, MI Alexiu-Toma, OA Ciornei, C Albu, A Nica, S Nistor, C Nica, R Balkan J Med Genet Original Article Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are diseases caused by the interaction of genetic and non-genetic factors. Therefore, the aim of our study was to investigate the association between six common genetic polymorphisms and T2DM and MetS in males. A total of 120 T2DM, 75 MetS, and 120 healthy controls (HC) were included in the study. ACE ID, eNOS 4a/b, ATR1 A1166C, OXTR (A>G), SOD1 +35A/C, CAT-21A/T gene polymorphisms were genotyped by PCR or PCR-RFLP techniques. T2DM was diagnosed at an earlier age compared to MetS (54 vs 55 years old, p=0.0003) and the difference was greater in carriers of the OXTR G allele (54 vs 56 years old, p=0.0002) or both OXTR G and eNOS b alleles (54 vs 56, p=0.00016). The SOD1 AA genotype (O.R.=0.11, p=0.0006) and the presence of both ACE I and OXTR1 A (O.R.=0.39, p=0.0005) alleles revealed to be protective for T2DM. SOD1 AA and AC genotypes were protective factors for triglyceride (p=0.0002 and p=0.0005, respectively) and HDL cholesterol (p=0.0002 and p=0.0004, respectively) levels in T2DM patients. ACE DD was identified more frequently in hypertensive T2DM patients (O.R.=3.77, p=0.0005) and in those who reported drinking alcohol (p=0.0001) comparing to HC and T2DM patients who did not drink alcohol, respectively. We observed that T2DM patients who reported drinking alcohol had an increased frequency of ACE DD and eNOS bb (p<0.0001), or ACE DD and OXTR G (p<0.0001) compared to non-drinkers. No gene polymorphisms were associated with MetS. Sciendo 2023-07-31 /pmc/articles/PMC10413885/ /pubmed/37576792 http://dx.doi.org/10.2478/bjmg-2023-0003 Text en © 2023 C Zenoaga-Barbăroșie et al., published by Sciendo https://creativecommons.org/licenses/by-nc-nd/3.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. |
spellingShingle | Original Article Zenoaga-Barbăroșie, C Berca, L Vassu-Dimov, T Toma, M Nica, MI Alexiu-Toma, OA Ciornei, C Albu, A Nica, S Nistor, C Nica, R The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome |
title | The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome |
title_full | The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome |
title_fullStr | The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome |
title_full_unstemmed | The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome |
title_short | The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome |
title_sort | predisposition for type 2 diabetes mellitus and metabolic syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413885/ https://www.ncbi.nlm.nih.gov/pubmed/37576792 http://dx.doi.org/10.2478/bjmg-2023-0003 |
work_keys_str_mv | AT zenoagabarbarosiec thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT bercal thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT vassudimovt thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT tomam thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT nicami thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT alexiutomaoa thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT ciorneic thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT albua thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT nicas thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT nistorc thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT nicar thepredispositionfortype2diabetesmellitusandmetabolicsyndrome AT zenoagabarbarosiec predispositionfortype2diabetesmellitusandmetabolicsyndrome AT bercal predispositionfortype2diabetesmellitusandmetabolicsyndrome AT vassudimovt predispositionfortype2diabetesmellitusandmetabolicsyndrome AT tomam predispositionfortype2diabetesmellitusandmetabolicsyndrome AT nicami predispositionfortype2diabetesmellitusandmetabolicsyndrome AT alexiutomaoa predispositionfortype2diabetesmellitusandmetabolicsyndrome AT ciorneic predispositionfortype2diabetesmellitusandmetabolicsyndrome AT albua predispositionfortype2diabetesmellitusandmetabolicsyndrome AT nicas predispositionfortype2diabetesmellitusandmetabolicsyndrome AT nistorc predispositionfortype2diabetesmellitusandmetabolicsyndrome AT nicar predispositionfortype2diabetesmellitusandmetabolicsyndrome |